Natriuretic peptides in coronary disease with non-ST elevation: New tools ready for clinical application?

Recent Patents on Cardiovascular Drug Discovery

Volumn 2, Issue 1, 2007, Pages 1-4

  Palazzuoli, Alberto ^a   Giannotti, Giovanna ^a   Iovine, Francesca ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Acute coronary syndromes; BNP; Coronary vessels; NTpro BNP; Prognosis; Stable angina

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; NATRIURETIC FACTOR; TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EXPERIMENTAL STUDY; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; LABORATORY DIAGNOSIS; PATENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 34249318444     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489007779606185     Document Type: Article

References (37)

1. Rutherford JD, Braunwald E. Coronary heart disease. In: Braunwald E, ed Heart Diseases 5th, 1997: 2; 1799-1869.
2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842
3. Hess, G., Horsch, A.: US20050239138A1 (2005).
4. Braunwald E. Unstable angina: an etiologic approach to management. Circulation 1998; 98: 2119-2222.
5. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-1995.
6. Forte RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced myocardial ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004; 44:1980-1987.
7. Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006; 151: 1223-1230.
8. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide ana ischemia in patients with stable coronary disease: data from Heart and Soul study. Circulation 2003; 108: 2987-2992.
9. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 1995; 88: 551-556.
10. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 2005; 118: 1287.e9-1287.e16.
11. Talwar S, Squire I B, Downie PF, Davies JE, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000; 84:421-424.
12. Sabatine MS, Morrow DA, De Lemos JA, Gibson CM Murphy SA, Rifai N, et al. E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Circulation 2002; 105: 1760-1763.
13. Dahlen, J.R., Valkirs, G.E., Buechler, K.F.: WO02083913A1 (2002).
14. Dahlen, J.R., Buechler, K.F., Valkirs, G.E.: CA2412648AA (2002).
15. Valkirs, G.E., Dahlen, JR., Kirchick, H., Buechler, Kenneth, F.: EP1666881A2 (2006).
16. Dahlen, J.R., Valkirs, G.E., Buechler, K.F.: EP1311701A1 (2003).
17. Buechler, K.F., Maisel, A., Anderberg, J.M., McPherson, P.H., Dahlen, J.R., Kirchick, H. J.: US20040253637A1 (2004).
18. Hess, G., Horsch, A.:WO05124364A1 (2005).
19. Ndrepepa G, Braun S, Niemoller K, Mehilli J, von Beckerath N, von Beckerath O, et al. Plasma levels of N-terminal Pro-brain Natriuretic Peptide in patients with Coronary Artery Disease and relation to clinical presentation, angiographic severity and left ventricular ejection fraction. Am J Cardiol 2005; 95: 553-57
20. Palazzuoli A, Gennari L, Calabria P, Quatrini I, Vecchiato L, De Paola V, et al. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol 2005; 96: 1705-1710. Epub 2005 Nov 2.
21. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, de Lemos JA, et al. Association of elevated B-Type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-st segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 564-8.
22. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida K, Kato H, et al. Icreased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996; 132: 101-107.
23. Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes moving toward multimarker strategy. Circulation 2003; 108: 250-252.
24. Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, et al. Plasma natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. A comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriurefic peptide. Circulation 1996; 93: 1963-969.
25. Arakawa N, Nakamura M, Aoki H, Hiramori H. Plasma brain natriuretic peptide concentration predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656-61.
26. Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary sydromes. Eur J Heart Fail 2004; 6: 327-33.
27. Hess, G., Horsch, A.: EP1577673A1 (2005).
28. Hess, G., Horsch, A.: JP2005274569A2 (2005).
29. Dahlen, J.R., Buechler, K.F., Valkirs, G.E.: US20030022235A1 (2003).
30. Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evalutation of B-type Natriuretic Peptide for risk assessment in unstable angina/non-ST elevation myocardial infarction. J Am Coll Cardiol 2003; 41: 1264-72.
31. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
32. Danne, O., Frei, U., Zschunke, A., Mugge, C.: US20046830932 (2004).
33. Morrow DA, de Lemos JA, Sabatine MA, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-Type Natriuretic Peptide for risk assessment in Unstable Angina/Non-ST-Elevation Myocardial Infarction. B-Type Natriuretic Peptide and Prognosis in TACTIS-TIMI 18. J Am Coll Cardiol 2003; 41: 1264-1272.
34. Galvani M, Ottani F, Oltrona L, Ardissimo D, Gensini GF, Maggioni AP, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes Circulation 2004 13;110:128-34.
35. Palazzuoli A, Poldermans D, Capobianco S, Giannotti G, Iovine F, Campagna MS, et al Rise and Fall of B-Type Natriuretic Peptide Levels in Patients with Coronary Artery Disease and Normal Left Ventricular Function After Cardiac Revascularization Coron Artery Dis. 2006;17: 419-23.
36. Talwar S, Squire IB, Downie PF et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 2000; 21: 1514-1521.
37. Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, et al. Prognostic value of serial B-Type Natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005; 294: 2866-2871.